Literature DB >> 10495056

Possible tardive dystonia resulting from clozapine therapy.

E S Molho1, S A Factor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10495056     DOI: 10.1002/1531-8257(199909)14:5<873::aid-mds1027>3.0.co;2-u

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  8 in total

1.  Tardive dyskinesia: therapeutic options for an increasingly common disorder.

Authors:  Leslie J Cloud; Deepti Zutshi; Stewart A Factor
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

2.  Clozapine-associated Pisa syndrome: A rare type of tardive dystonia.

Authors:  Pattath Narayanan Suresh Kumar; Arun Gopalakrishnan
Journal:  Indian J Psychiatry       Date:  2017 Jul-Sep       Impact factor: 1.759

Review 3.  Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies.

Authors:  Katharina Stegmayer; Sebastian Walther; Peter van Harten
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

Review 4.  Atypical antipsychotics and mood stabilization in bipolar disorder.

Authors:  Paolo Brambilla; Francesco Barale; Jair C Soares
Journal:  Psychopharmacology (Berl)       Date:  2003-02-27       Impact factor: 4.530

5.  Tardive oculogyric crisis during treatment with clozapine: report of three cases.

Authors:  Ozcan Uzun; Ali Doruk
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 6.  Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors.

Authors:  Nicki Niemann; Joseph Jankovic
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

Review 7.  An Update on the Treatment of Chorea.

Authors:  Erin Feinstein; Ruth Walker
Journal:  Curr Treat Options Neurol       Date:  2018-09-25       Impact factor: 3.598

8.  Olanzapine induced tardive dystonia.

Authors:  Ashish Aggarwal; R C Jiloha
Journal:  Indian J Pharmacol       Date:  2008-10       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.